The myelin sheath's sulfate badge: a galactosylceramide bearing a sulfate ester on the third carbon of its sugar. Sulfatide supplies 4–7% of myelin's lipid; losing the enzyme that degrades it causes metachromatic leukodystrophy.
Influenza A hemagglutinin binds it and replication rises 500–3,000-fold in sulfatide-enriched cells; HIV-1, hepatitis C and vaccinia also engage it.
Bacteria from E. coli to H. pylori use sulfatide to adhere to mucosal surfaces.
Apolipoprotein E tracks the sulfatide loss of Alzheimer disease; anti-sulfatide antibodies mark multiple sclerosis.
Clinical Relevance
Metachromatic leukodystrophy: arylsulfatase A under 10% of normal (autosomal recessive; one in 40,000–160,000) accumulates sulfatide and destroys myelin; the late-infantile form, half of cases, kills untreated children by age five. Gene therapy now treats pre-symptomatic children.
Alzheimer disease: sulfatide drops up to 50% in white matter and 90% in gray at the mildest stage — among the earliest lipid changes known.
Overexpressed in colorectal, lung, ovarian, renal and gastric cancers as a P-selectin ligand favoring metastasis; dosing diabetes-prone mice cuts incidence from 85% to 35%.